Skip to main content
Voyageur Pharmaceuticals Ltd. logo

Voyageur Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · VM ISIN · CA92918C1014 TSXV Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2020-11-11 Regulatory Filings
Country CA Canada
Listing TSXV VM

About Voyageur Pharmaceuticals Ltd.

https://voyageurpharmaceuticals.ca/

Voyageur Pharmaceuticals Ltd. develops and supplies contrast media products for medical imaging, including CT scans and fluoroscopy. The company operates using a vertically integrated "Earth to Bottle" strategy, controlling the entire supply chain from raw mineral acquisition to finished pharmaceutical product. Voyageur owns a significant, high-purity barium sulfate resource, positioning it as a secure and sustainable supplier of pharmaceutical-grade barium sulfate, the active ingredient in its commercialized contrast agents (e.g., SmoothX® and SmoothHD® series). This vertical control aims to ensure supply security and cost competitiveness, primarily targeting the North American market. The company is also actively developing iodine-based contrast media and V-Gas® Effervescent Granules to expand its portfolio of diagnostic imaging solutions.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 51-102F3 Material Change Report' and describes a material change event for Voyageur Minerals Ltd. It details the filing of an updated NI 43-101 Technical Report and ongoing work on a Preliminary Economic Assessment and Pre-Feasibility study. The document is a regulatory disclosure about a material change, referencing National Instrument 51-102 Continuous Disclosure Obligations, which is a Canadian securities regulation. It is not a full financial report, audit, earnings release, or management discussion. It is a specific regulatory filing to disclose material changes to investors and regulators. The document length is about 4984 characters, which is consistent with a material change report rather than a full report or announcement of a report. Therefore, the best classification is Regulatory Filings (RNS), as it is a regulatory disclosure document that does not fit other specific categories like Annual Report or Earnings Release.
2020-11-11 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the filing of an updated NI 43-101 Technical Report related to a mining project (Frances Creek Project) and the completion of a mine site visit for advancement of a Preliminary Economic Assessment (PEA). It discusses project milestones, technical assessments, and forward-looking statements about the company's plans and operations. The document does not contain actual financial statements or detailed financial performance data. It is an announcement of a technical report filing and project progress rather than the report itself or a financial report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and filings that do not fit other specific categories.
2020-11-03 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate, signed by the CFO, certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended August 31, 2020. It is a certification letter rather than the interim report itself. The document is short (3001 characters) and primarily an officer certification. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS), not as the interim report (IR) it references.
2020-10-30 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate. It is a certification by the CEO regarding the review and fair presentation of the interim financial report and interim MD&A for the period ended August 31, 2020. The document does not contain actual financial data or substantive financial analysis but is an officer certification related to interim filings. According to the Certification Rule, such certifications should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3034 characters), and it is clearly a certification form, not the full interim report.
2020-10-30 English
Interim MD&A - English.pdf
Regulatory Filings
2020-10-30 English
Interim financial statements/report – English.pdf
Regulatory Filings
2020-10-30 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.